Identity
What is MOTS-c?
A mitochondrial-derived peptide encoded within the 12S rRNA gene (sequence MRWQEMGYIFYPRKLR).

Research reference · Cellular Energy
MOTS-c is a 16-residue peptide encoded in mitochondrial DNA. It was first described in 2015 and is studied in cell and animal models of metabolism and exercise.
Published by Elevated Pharma ·
Identity
A mitochondrial-derived peptide encoded within the 12S rRNA gene (sequence MRWQEMGYIFYPRKLR).
Research context
Most work is in cells and mice. Human studies so far measure natural MOTS-c levels in blood, for example after exercise; they do not test MOTS-c given as a drug.
Evidence boundary
Preclinical findings do not establish human safety, clinical effectiveness or a material specification.
U.S. status · November 7, 2026
FDA removed it from its Category 2 compounding list in April 2026, and FDA’s compounding advisory committee recommended it for the 503A bulks list on July 23, 2026 (vote 7–5, two abstentions). On October 28, 2026, HHS issued an interim policy saying it will not take enforcement action against licensed pharmacies and physicians that compound it under listed conditions, such as FDA-registered sourcing, a certificate of analysis and safety reporting. It is not FDA-approved, and the policy does not cover research-use-only material.
HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.
Read the sourceFDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).
Read the sourceKey studies
Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.
Search all 264 PubMed records for MOTS-c · Counts and selections checked November 7, 2026.
Reference identifiers
Database identity describes the reference substance, not any specific material or lot.
Official & primary sources
Citation does not imply an Elevated Pharma partnership or endorsement.